BAYER AG |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 27.4 EUR | +1.88% |
|
+4.08% | -18.53% |
| Apr. 26 | Bayer CEO wins first AGM shareholder vote | RE |
| Apr. 26 | BAYER SAYS INVESTORS WITH 91.69% OF EQUITY CAPITAL REPRESENTED A… | RE |
ETFs positioned on Bayer AG
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 9.77% | 70 M€ | -.--% | - | |
| 5.71% | 2 M€ | +13.56% | - | |
| 4.28% | 962 M€ | -.--% | - | |
| 4.10% | 0 M€ | 0.00% | - | |
| 3.33% | 18 M€ | +7.68% | ||
| 3.03% | 79 M€ | -.--% | ||
| 1.91% | 134 M€ | -.--% | - | |
| 1.63% | 264 M€ | +13.50% | - | |
| 1.52% | 18 M€ | +3.79% | - | |
| 0.79% | 6 M€ | -.--% | - | |
| 0.53% | 6 M€ | -.--% | ||
| 0.42% | 1,120 M€ | +0.40% | ||
| 0.31% | 7 M€ | +1.95% | - | |
| 0.30% | 10 M€ | -3.35% | - | |
| 0.28% | 76 M€ | +6.75% | - | |
| 0.18% | 31 M€ | +3.50% | - | |
| 0.14% | 29 M€ | +8.37% | - | |
| 0.13% | 273 M€ | +15.83% | ||
| 0.09% | 1,166 M€ | +0.26% | - | |
| 0.09% | 607 M€ | +0.05% | - | |
| 0.09% | 0 M€ | 0.00% | - |
Bayer AG is one of the world's leaders in designing, producing, and marketing pharmaceutical products and agrochemicals. Net sales are distributed by product family as follows:
- agrochemicals (48.8%): herbicides, fungicides, insecticides, etc.;
- pharmaceutical products (38%): intended for the prevention and treatment of cardiovascular and respiratory diseases, diabetes, nervous system disorders, etc.;
- OTC products and nutritional supplements (12.7%);
- other (0.5%).
Net sales are distributed geographically as follows: Germany (5.1%), Switzerland (1.2%), Europe-Middle East-Africa (23.2%), the United States (30.6%), North America (3.5%), China (7.6%), Asia-Pacific (10%), Brazil (10.4%) and Latin America (8.4%).
Sector
Pharmaceuticals
Calendar
2024-04-28
- Ex-dividend day for final dividend
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
21
Last Close Price
27.4
EUR
Average target price
36.9
EUR
Spread / Average Target
+34.69%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -18.53% | 28.74B | |
| +25.83% | 661B | |
| +27.00% | 566B | |
| -6.76% | 352B | |
| +20.34% | 332B | |
| +3.00% | 283B | |
| +13.09% | 231B | |
| +5.46% | 200B | |
| -9.61% | 195B | |
| -6.26% | 145B |
- Stock Market
- Equities
- BAYN Stock
- Funds and ETFs Bayer AG
